See also: Generic Megace ES
Megace is a brand name of megestrol, approved by the FDA in the following formulation(s):
MEGACE (megestrol acetate - suspension; oral)
Manufacturer: BRISTOL MYERS SQUIBB
Approval date: September 10, 1993
Strength(s): 40MG/ML [RLD][AB]
Has a generic version of Megace been approved?
A generic version of Megace has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Megace and have been approved by the FDA:
megestrol acetate suspension; oral
Manufacturer: APOTEX INC
Approval date: February 16, 2006
Strength(s): 40MG/ML [AB]
Manufacturer: PAR PHARM
Approval date: July 25, 2001
Strength(s): 40MG/ML [AB]
Manufacturer: ROXANE
Approval date: February 15, 2002
Strength(s): 40MG/ML [AB]
Manufacturer: TEVA PHARMS
Approval date: May 5, 2003
Strength(s): 40MG/ML [AB]
Manufacturer: WOCKHARDT
Approval date: November 1, 2004
Strength(s): 40MG/ML [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Megace. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Megestrol acetate formulation
Patent 5,338,732
Issued: August 16, 1994
Inventor(s): Atzinger; Anne E. & Bequette; Robert J. & Davis; Robert E.
Assignee(s): Bristol-Myers Squibb Company
The present invention relates to a novel oral pharmaceutical composition of micronized megestrol acetate at a concentration of 15 to 150 mg/mL comprising polysorbate at a concentration of 0.005% to 0.015% weight/volume and polyethylene glycol at a concentration of 5-30% weight/volume which composition forms a stable flocculated suspension in water. The invention further comprises the micronized megestrol acetate formulation described above with added preservatives, buffers, sweeteners and flavoring agents.Patent expiration dates:
- August 16, 2011
- August 16, 2011
See also...
- Megace Suspension Consumer Information (Wolters Kluwer)
- Megace Consumer Information (Cerner Multum)
- Megace AHFS DI Monographs (ASHP)
- Megestrol Consumer Information (Wolters Kluwer)
- Megestrol Suspension Consumer Information (Wolters Kluwer)
- Megestrol Consumer Information (Cerner Multum)
- Megestrol Acetate AHFS DI Monographs (ASHP)
